4//SEC Filing
Beckman Richard 4
Accession 0001209191-22-050957
CIK 0001501756other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 8:01 PM ET
Size
5.8 KB
Accession
0001209191-22-050957
Insider Transaction Report
Form 4
Beckman Richard
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-09-19$1.07/sh−4,272$4,570→ 39,061 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]The reporting person's sale of Adverum common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of the same number of shares of Adverum common stock at a price of $0.8228 per share on May 17, 2022. The reporting person has paid to Adverum $1,055.01, representing the full amount of the profit realized in connection with the short-swing transaction.
- [F3]Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.0721. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001908942
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 8:01 PM ET
- Size
- 5.8 KB